BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.2//EN BEGIN:VEVENT DESCRIPTION:Event highlightsMore than 120 representatives from national imm unization programmes\, partner organizations and advisory bodies joined th is webinar to listen to the latest regional progress towards the European Immunization Agenda 2030 (EIA2030) goals.The programme provided an in-dept h look at implementation across the WHO European Region\, drawing on findi ngs from the 2025 EIA2030 Technical Progress Report based on 2024 data. Pr esentations highlighted performance against the 7 impact goal indicators c overing disease control\, equity and strengthening primary health care. Th e analysis showed that only 1 indicator is currently on track\, while 5 re main substantially off-track and 1 is progressing slowly. The session also examined how Member States have acted on the previous year&rsquo\;s recom mendations from the European Technical Advisory Group of Experts on Immuni zation (ETAGE). Dr Ole Wichmann\, Chair of ETAGE\, presented the group&rsq uo\;s latest conclusions and recommendations to Member States and WHO on a ctions needed to accelerate progress towards the agreed EIA2030 milestones and targets.The webinar further emphasized the importance of high-quality \, timely reporting\, and showed how country-reported data are compiled\, visualized and used to inform regional monitoring and decision-making. Pos t-webinar feedback indicated that almost all respondents found the session useful.Event noticeAs part of the European Immunization Agenda 2030&rsquo \;s (EIA2030) monitoring\, evaluation and accountability process\, WHO/Eur ope produces an annual technical progress report and annually updates the online EIA2030 dashboard\, which visualizes advancements towards milestone s and targets at both regional and country levels.The aim of this webinar is to update Member States and other EIA2030 stakeholders on EIA2030 imple mentation progress\, share key information and guidance and present the re commendations of the European Technical Advisory Group of Experts on Immun ization (ETAGE) to accelerate progress towards EIA2030 targets and goals. ParticipantsInvited participants include representatives of all 53 Member States (immunization programme managers\, focal points for the reporting o f immunization programme performance and vaccine-preventable disease surve illance data)\, national and regional expert committees (including ETAGE) and WHO headquarters and partner agencies engaged in supporting immunizati on programmes in the WHO European Region (including the European Commissio n\, European Union Directorate-General for Health and Food Safety\, Europe an Centre for Disease Prevention and Control and United Nations Children&r squo\;s Fund). \; BackgroundEIA2030 defines a vision and strategy to a chieve the full benefits of immunization in the Region. Endorsed by Member States in September 2021\, EIA2030 provides a framework for coordinated a ction to strengthen immunization programmes and reach regional targets. Fo r more information\, contact euvaccine@who.int. DTEND;VALUE=DATE:20260211 DTSTAMP:20260405T214904Z DTSTART;VALUE=DATE:20260210 LOCATION:Online\,10:00–12:00 (CET) SEQUENCE:0 SUMMARY:Webinar: annual update on implementation of the European Immunizati on Agenda 2030 (EIA2030) UID:RFCALITEM639110225447063532 X-ALT-DESC;FMTTYPE=text/html:

Event highlights

More than 120 repr esentatives from national immunization programmes\, partner organizations and advisory bodies joined this webinar to listen to the latest regional p rogress towards the European Immunization Agenda 2030 (EIA2030) goals.

The programme provided an in-depth look at implementation across the WH O European Region\, drawing on findings from the 2025 EIA2030 Technical Pr ogress Report based on 2024 data. Presentations highlighted performance ag ainst the 7 impact goal indicators covering disease control\, equity and s trengthening primary health care. The analysis showed that only 1 indicato r is currently on track\, while 5 remain substantially off-track and 1 is progressing slowly. The session also examined how Member States have acted on the previous year&rsquo\;s recommendations from the European Technical Advisory Group of Experts on Immunization (ETAGE). Dr Ole Wichmann\, Chai r of ETAGE\, presented the group&rsquo\;s latest conclusions and recommend ations to Member States and WHO on actions needed to accelerate progress t owards the agreed EIA2030 milestones and targets.

The webinar furthe r emphasized the importance of high-quality\, timely reporting\, and showe d how country-reported data are compiled\, visualized and used to inform r egional monitoring and decision-making. Post-webinar feedback indicated th at almost all respondents found the session useful.

Ev ent notice

As part of the European Immunization Agenda 2030&rsquo\; s (EIA2030) monitoring\, evaluation and accountability pr ocess\, WHO/Europe produces an annual technical progress report and annual ly updates the online EIA2030 dashboard\, which visualizes advancements to wards milestones and targets at both regional and country levels.

Th e aim of this webinar is to update Member States and other EIA2030 stakeho lders on EIA2030 implementation progress\, share key information and guida nce and present the recommendations of the European Technical Advisory Gro up of Experts on Immunization (ETAGE) to accelerate progress towards EIA20 30 targets and goals.

Participants

Invited partici pants include representatives of all 53 Member States (immunization progra mme managers\, focal points for the reporting of immunization programme pe rformance and vaccine-preventable disease surveillance data)\, national an d regional expert committees (including ETAGE) and WHO headquarters and pa rtner agencies engaged in supporting immunization programmes in the WHO Eu ropean Region (including the European Commission\, European Union Director ate-General for Health and Food Safety\, European Centre for Disease Preve ntion and Control and United Nations Children&rsquo\;s Fund). \;

< h3>Background

EIA2030 defines a vision and strategy to ach ieve the full benefits of immunization in the Region. Endorsed by Member S tates in September 2021\, EIA2030 provides a framework for coordinated act ion to strengthen immunization programmes and reach regional targets. For more information\, contact euvaccine@wh o.int.

END:VEVENT END:VCALENDAR